Phoenix Medspa and Aesthetic Practice Biologics Supplier

How medspas and aesthetic practices evaluate suppliers

Aesthetic practices adding a new biologics line typically request the same category of documentation a surgical practice would: donor screening summary, processing description, and sterility testing results tied to the specific lot. Precision Biologics provides a certificate of analysis, donor eligibility summary, and lot release record to verified accounts, with full ingredient disclosure available for exosome products.

Because Wharton's jelly and exosome products carry different regulatory considerations, practices generally review documentation for each product line on its own rather than treating one review as covering both.

• Certificate of analysis
• Donor eligibility summary
• Lot release record
• Full ingredient disclosure (exosome products)

Account verification and physician supervision

Every account is tied to a licensed physician's NPI number and verified against the NPPES registry before the first order is processed, whether the ordering entity is a dermatology practice, a plastic surgery practice, or a medspa operating under physician supervision.

This verification confirms licensure status. It does not determine whether a specific product or intended use fits a practice's regulatory posture, which remains a decision for the practice and its own counsel.

Shipping logistics to the Southwest

Cryopreserved Wharton's jelly products ship overnight on dry ice in validated containers and move to -80 degree C storage on arrival, so practices should have a staff member ready to receive and store the shipment promptly. Lyophilized exosome products are shelf-stable and ship without cryogenic packaging, with handling instructions included in the product insert for that lot.

Documentation available to verified accounts

Before formalizing a vendor relationship, aesthetic practices in Arizona typically confirm their regulatory posture with the Arizona Medical Board, or the applicable licensing board for the supervising physician, and with independent counsel. Precision Biologics supports account setup with peer-to-peer physician calls about documentation, not clinical advice.

These products are not FDA approved or licensed for any disease or condition. Information here is for licensed healthcare professionals and is not medical or legal advice.

FDA has stated there are no FDA-approved exosome products. Exosome products are generally regulated as biologic drugs under section 351 of the Public Health Service Act, not as 361 HCT/Ps. Purchase and clinical use decisions belong to the physician with their own regulatory counsel.

These products are not FDA approved or licensed for any disease or condition. Information is for licensed healthcare professionals and is not medical or legal advice.